首页    期刊浏览 2025年02月12日 星期三
登录注册

文章基本信息

  • 标题:Divergences between mHealth drug interaction checkers: a highlight on HIV hospitalized patients therapy
  • 本地全文:下载
  • 作者:Pedro Ivo da Silva ; Roberta Rosa Souza ; Paulo César Cascao
  • 期刊名称:Research, Society and Development
  • 电子版ISSN:2525-3409
  • 出版年度:2021
  • 卷号:10
  • 期号:7
  • 页码:1-11
  • DOI:10.33448/rsd-v10i7.15759
  • 语种:English
  • 出版社:Grupo de Pesquisa Metodologias em Ensino e Aprendizagem em Ciências
  • 摘要:Introduction: Mobile health (mHealth) apps have been involved in contemporary clinical practice in potential drug-drug interactions (pDDIs) research. However, available pDDIs information may differ between apps, which could impact the success of patient's drug therapy. This study analyzed the performance of the mHealth apps in a context of pharmacotherapy prescribed to HIV/AIDS hospitalized patients. Methods: Cross-sectional study was conducted in a referral hospital for infectious diseases, central Brazil. Drug prescriptions were selected randomly by census. A pDDIs prevalence, severity classification as well the agreement of information and performance of different mHealth checkers were analyzed. Free access mHealth apps were selected: Drugs, EpocratesRx, and Micromedex (considered as reference app). Analysis of sensitivity, specificity, positive or negative predictive values (PPV or NPV) was conducted. Results: The majority of 33 HIV/AIDS hospitalized patients was males, young adults, with opportunistic infections despite of a recent HIV diagnosis. 373 drugs were prescribed with 461 pDDIs identified by mHealth checkers. The pDDIs prevalence was 13.9% (12.4-15.6), 22.2% (20.1-24.5) and 24.8% (22.9-26.8) in Micromedex, EpocratesRx and Drugs, respectively. Micromedex classified most of pDDIs (71.2%) as major, while Drugs (67.6%) and EpocratesRx (84.8%) classified most of them as minor. In comparison with Micromedex, Drugs or EpocratesRx showed none (KK=0.11) agreement in identification of pDDIs, respectively. Performance analyzes showed that Drugs presented greater sensitivity (75.4%), however, the results of specificity, PPV, NPV, and accuracy were similar by both apps when compared to the reference. Conclusion: The mHealth drug interaction checkers presented important divergences in the results of identification, classification of severity and prevalence rate of pDDIs.
  • 关键词:Drug prescriptions;Mobile Device;HIV Infections;Drug interaction;Mobile Health;Smartphone.
国家哲学社会科学文献中心版权所有